Four weeks into the new year, many of us have already swapped ambitious goals of running marathons for slightly more realistic ones like hitting 10K steps a day. It’s what happens when systems meet reality. Research indicates that the resolutions that actually stick are the ones backed by signals: feedback loops, progress tracking, and the ability to course-correct as life happens.
That’s exactly what healthcare and pharma are learning at scale: patient outcomes improve when decisions are guided by continuous, connected data rather than fragmented snapshots. For years, critical information lived in silos: clinical trials in one system, diagnostics in another, research, nutrition, and supply chains scattered across disconnected platforms. Today, applied AI and modern data platforms are connecting those dots. GenAI unlocks decades of pharmaceutical research, predictive analytics refines diagnostic pathways, and metadata-driven pipelines ensure pediatric nutrition reaches families reliably.
By unifying patient records, imaging, lab results, and genomics into governed, continuously improving systems, healthcare is moving toward ethical, context-aware intelligence. In this edition of AI of the Tiger, we explore how the shift is taking shape, and why better-connected data is becoming just as critical as the care it enables.
Smarter Search Powering the Big Breakthroughs
The next big medical breakthrough may just be around the corner. The challenge is finding it in time. Drug discovery rarely slows down because of science; it slows down because critical insight is trapped across disconnected research archives. A global pharmaceutical company partnered with us to change that. We built a GenAI-based information retrieval system that interprets complex clinical and commercial research language, retrieves relevant evidence in real time, and synthesizes it into actionable answers for researchers. Deployed on a scalable cloud foundation with continuous expert feedback loops, the system reduced query response times to 9 seconds and achieved a 75% SME acceptance rate, accelerating research cycles.
An Intelligent Partner for Faster Diagnoses, Precise Care
Precision meets pressure in cancer staging. Misclassify the stage, and treatment paths and outcomes quickly drift off course. A leading pharmaceutical company partnered with us to modernize disease progression prediction across markets. We built a multi-indication ML framework on AWS SageMaker that orchestrates XGBoost models to classify cancer stages in a governed MLOps environment, with model performance automatically validated, registered, and visualized in Amazon QuickSight for real-time decision support. Designed to augment clinical judgment, this scalable prediction engine improved diagnostic accuracy, reduced manual analysis, and enabled more targeted medication campaigns for the patients who need them most.
The Proof is in the Pipeline Architecture
When millions of parents rely on the right formula every day, getting the data right is crucial. Even a minor change can ripple through manufacturing, planning, and compliance worldwide. Mead Johnson Nutrition hit that exact inflection point during its SAP S/4HANA modernization, needing to rebuild how 140+ business-critical tables were replicated and consumed across analytics teams. We engineered a metadata-driven and auditable data pipeline architecture using SAP DataSphere, Azure Data Factory, and Databricks, replacing legacy SQL Server bottlenecks with near real-time delta ingestion, automated staging and history layers, and governed cloud-native access through Unity Catalog and CI/CD pipelines. The result: faster and more reliable reporting, reduced manual overhead, and a scalable data foundation that helps MJN translate pediatric nutrition science into consistently delivered products across global markets.
Unified, Supervised Intelligence for the Full Picture
From improving diagnostic accuracy and enabling personalized treatment, to powering remote care, long-term disease management, and accelerating drug discovery, AI is already reshaping healthcare. But none of this works in isolation; it depends on bringing fragmented health data, such as clinical records, imaging, genomics, labs, and real-time monitoring, into a unified, continuously learning system that can see the whole patient. That’s where responsible AI becomes essential, ensuring these predictive and decision-support models are governed, explainable, and built with privacy and oversight at the core, so patients know their information is managed right and healthcare teams can move faster without compromising trust.
From predictive models to metadata-driven pipelines, the systems being built today are laying the foundation for better decisions across healthcare. Where do you see connected intelligence having the biggest impact on patient outcomes over the next five years?
